Downloads

Income statement according to HGB

Financial statements of the Carl Zeiss Meditec AG – Income statement according to HGB

 

 

Note

 

2024/25
1 Oct 24 to 30 Sep 25

 

2023/24
1 Oct 23 to 30 Sep 24

 

 

 

 

€k

 

€k

Revenue

 

16

 

1,475,996

 

1,418,434

Decrease in finished goods and work in progress

 

 

 

-19,932

 

-21,765

Other own work capitalized

 

 

 

6,795

 

24,160

Other operating income

 

17

 

59,503

 

70,230

Cost of materials

 

 

 

-614,159

 

-602,405

a) Cost of raw materials, consumables and supplies, and of purchased merchandise

 

 

 

-608,465

 

-597,250

b) Cost of purchased services

 

 

 

-5,694

 

-5,155

Personnel expenses

 

 

 

307,966

 

295,282

a) Wages and salaries

 

 

 

-246,496

 

-233,264

b) Social security, post-employment and other employee benefit costs

 

 

 

-61,470

 

-62,018

» thereof for pensions

 

 

 

-23,295

 

-26,690

Write-downs on intangible assets and property, plant and equipment

 

 

 

-29,504

 

-30,194

Other operating expenses

 

18

 

-388,348

 

360,352

Income from long-term equity investments

 

19

 

3,835

 

0

» thereof from affiliated companies

 

 

 

3,835

 

0

Income from profit and loss transfer agreements

 

20

 

79

 

0

Expenses from loss transfers

 

20

 

0

 

-2,661

Income from long-term loans

 

 

 

4,910

 

4,130

» thereof from affiliated companies

 

 

 

4,910

 

4,130

Other interest and similar income

 

21

 

3,122

 

30,251

» thereof from affiliated companies

 

 

 

183

 

14,375

Write-downs of long-term financial assets and securities classified as current assets

 

 

 

-50

 

-7,910

Interest and similar expenses

 

22

 

-16,471

 

-9,184

» thereof to affiliated companies

 

 

 

-16,304

 

-8,941

Result before tax

 

 

 

177,810

 

217,452

Taxes on income

 

23

 

-56,129

 

-62,112

Result after tax

 

 

 

121,681

 

155,340

Other taxes

 

24

 

-381

 

341

Net income for the fiscal year

 

 

 

121,300

 

155,681

Share